U.S.-China Trade Tensions Ease Following Landmark Presidential Summit

Following a high-stakes, 100-minute meeting in Busan, South Korea—the first in-person summit between the two leaders in six years—President Donald Trump and President Xi Jinping have announced a partial de-escalation of the ongoing trade war. While a comprehensive trade agreement remains pending, the two nations reached specific accords regarding fentanyl regulation and critical mineral exports. The U.S. has agreed to slash tariffs on Chinese fentanyl-related goods from 20% to 10%, a move President Trump signaled as a reward for Beijing’s commitment to curbing the flow of synthetic opioids and precursor chemicals. Furthermore, the overall tariff rate on Chinese imports is set to decrease from 57% to 47%. In a reciprocal gesture, Beijing has agreed to a one-year suspension of its recently announced export controls on rare earth minerals, which had previously triggered threats of 100% retaliatory tariffs from the White House. While the U.S. has officially withdrawn those tariff threats, ambiguity remains regarding the long-term status of these export restrictions, as Chinese officials indicated they would only 'study and refine' the measures after the one-year pause. Despite the progress, many core trade issues remain unresolved, and existing tariffs on Chinese goods remain at historically elevated levels.